Key result
Drug-eluting stents cut post-PCI restenosis ~75% compared to bare-metal stents.
Answers are grounded in this paper and cite their sources.
Percutaneous coronary intervention (PCI) has become the most important revascularization method in the treatment of coronary artery disease. The major problem in PCI has been renarrowing of the dilated vessel after the procedure (restenosis). The best results in the prevention of restenosis have been obtained by covering the stent with drugs that inhibit cellular growth, thus limiting excessive scar formation inside of the stent. With drug-eluting stents, restenosis has been reduced to one-tenth compared with balloon angioplasty and to one-fourth compared to bare metal stents. Due to drug-eluting stents, PCI is an alternative to bypass surgery. However, restenosis will remain a challenge due to the increased number of procedures and more difficult disease treated with PCI.
No takes yet. Share an insight, caveat, or question.
Kivelä et al. (2006) conducted a review in Coronary artery disease. Drug-eluting stents vs. Bare metal stents and balloon angioplasty was evaluated on Restenosis. Drug-eluting stents have reduced restenosis after PCI to one-tenth compared with balloon angioplasty and to one-fourth compared with bare metal stents.
Synapse has enriched 10 related papers. Consider them for comparative context: